Allergan Eyes Edema, Macular Degeneration Indications With Oculex Buy
This article was originally published in The Gray Sheet
Executive Summary
Allergan could enter the retinal therapy market in late 2006 with Oculex' macular edema implant Posurdex, following its $230 mil. acquisition of the tech firm